PAVmed (PAVM) Change in Account Payables (2015 - 2025)
PAVmed's (PAVM) quarterly Change in Account Payables came in at $339000.0 in Q4 2025, up 78.42% year-on-year from $190000.0 in Q4 2024, and up 821.28% quarter-over-quarter from -$47000.0 in Q3 2025.
PAVmed (PAVM) Change in Account Payables (2015 - 2025) Analysis & Trends
PAVmed's Change in Account Payables history runs 11 years deep, the most recent figure standing at $339000.0 for Q4 2025.
- On a quarterly basis, Change in Account Payables rose 78.42% year-over-year to $339000.0 in Q4 2025; TTM through Dec 2025 was $24000.0, a 103.23% increase from a year earlier, with the FY2025 full-year figure at $24000.0, up 140.68% from the prior year.
- Change in Account Payables improved to $339000.0 in Q4 2025 per PAVM's latest filing, from -$47000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.9 million in Q1 2022 and bottomed at -$2.9 million in Q2 2022.
- The 5-year median for Change in Account Payables is -$97000.0 (2023), against an average of -$96052.6.
- Biggest YoY gain for Change in Account Payables was 612.7% in 2021; the steepest drop was 675.35% in 2021.
- Year by year, Change in Account Payables stood at -$2.7 million in 2021, then surged by 108.73% to $239000.0 in 2022, then tumbled by 259.0% to -$380000.0 in 2023, then jumped by 150.0% to $190000.0 in 2024, then soared by 78.42% to $339000.0 in 2025.
- Per Business Quant, the three latest PAVM Change in Account Payables figures stand at $339000.0 (Q4 2025), -$47000.0 (Q3 2025), and $18000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | 221.00 Mn |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | - |
| 10 | PAVmed | 11.18 Mn | 9.64 Mn | -4,000.00 | 339,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 339,000.00 |
| Dec 31, 2025 | 339,000.00 |
| Sep 30, 2025 | -47,000.00 |
| Sep 30, 2025 | -47,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | -286,000.00 |
| Mar 31, 2025 | -286,000.00 |
| Dec 31, 2024 | 190,000.00 |
| Dec 31, 2024 | 190,000.00 |
| Jun 30, 2024 | -252,000.00 |
| Jun 30, 2024 | -252,000.00 |
| Mar 31, 2024 | -301,000.00 |
| Mar 31, 2024 | -301,000.00 |
| Dec 31, 2023 | -380,000.00 |
| Dec 31, 2023 | -380,000.00 |
| Sep 30, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | -97,000.00 |
| Jun 30, 2023 | -97,000.00 |